Assessment of tumor response to neoadjuvant chemotherapy in patients with breast cancer using MRI and FDG-PET/CT-RECIST 1.1 vs. PERCIST 1.0.

Kitajima, Kazuhiro; Miyoshi, Yasuo; Yamano, Toshiko; Odawara, Soichi; Higuchi, Tomoko; Yamakado, Koichiro

Kitajima, Kazuhiro; Miyoshi, Yasuo; Yamano, Toshiko; Odawara, Soichi; Higuchi, Tomoko; Yamakado, Koichiro.

Afiliação

Kitajima K; Department of Radiology, Division of Nuclear Medicine and PET Center, Hyogo College of Medicine, Nishinomiya, Japan.
Miyoshi Y; Department of Breast and Endocrine Surgery, Hyogo College of Medicine, Nishinomiya, Japan.
Yamano T; Department of Radiology, Hyogo College of Medicine, Nishinomiya, Japan.
Odawara S; Department of Radiology, Hyogo College of Medicine, Nishinomiya, Japan.
Higuchi T; Department of Breast and Endocrine Surgery, Hyogo College of Medicine, Nishinomiya, Japan.
Yamakado K; Department of Radiology, Hyogo College of Medicine, Nishinomiya, Japan.

Nagoya J Med Sci ; 80(2): 183-197, 2018 May.

Article em En | MEDLINE | ID: mdl-29915436

Palavras-chave

FDG-PET/CT; PERCIST; RECIST; breast cancer; treatment response

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Nagoya J Med Sci Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google